News tagged with cancer survival
Researchers find important 'target' playing role in tobacco-related lung cancers
Researchers at Moffitt Cancer Center in Tampa, Fla., have discovered that the immune response regulator IKBKE (serine/threonine kinase) plays two roles in tobacco-related non-small cell lung cancers. Tobacco carcinogens induce ...
Feb 09, 2012 |
5 / 5 (1) |
0
How early breast tumors become deadly: A small group of molecules might hold the answer
Researchers have discovered a restricted pattern of molecules that differentiate early-stage breast tumors from invasive, life-threatening cancer. They also found a similar molecular signature that correlated with the aggressiveness ...
Feb 07, 2012 |
5 / 5 (2) |
0
|
Balancing oxaliplatin dose with neurological side effects in metastatic colon cancer
The drug oxaliplatin is a major reason the prognosis for metastatic colon cancer has gone from an expected survival of several months to a couple years. Unfortunately, the drug can also carry with it debilitating neurological ...
Feb 02, 2012 |
5 / 5 (1) |
0
New drug extends survival in patients with drug-resistant prostate cancer
A new drug, MDV3100, is improving the survival rate in men with advanced prostate cancer, results of a large, phase III clinical trial show. The drug is designed to block a type of cellular receptor that drives progression ...
Feb 01, 2012 |
5 / 5 (1) |
0
|
Study defines a new genetic subtype of lung cancer
A report from investigators at the Massachusetts General Hospital (MGH) Cancer Center has defined the role of a recently identified gene abnormality in a deadly form of lung cancer. Tumors driven by rearrangements in the ...
Jan 31, 2012 |
not rated yet |
0
|
Four-week vaccination regimen knocks out early breast cancer tumors, researchers find
Researchers at the Perelman School of Medicine at the University of Pennsylvania report that a short course of vaccination with an anti-HER2 dendritic cell vaccine made partly from the patient's own cells triggers a complete ...
Jan 30, 2012 |
5 / 5 (4) |
0
|
New method to manage stress responses for more successful tumor removal
The week before and two weeks after surgery are a critical period for the long-term survival rate of cancer patients. Physiological and psychological stresses caused by the surgery itself can inhibit the body's immune responses, ...
Jan 30, 2012 |
not rated yet |
0
Standard treatments for head and neck cancer less effective in HIV-positive patients
Radiation therapy with or without chemotherapy is less effective for patients with HIV when compared to the recurrence and overall survival rates in patients who do not have HIV, according to a study presented at the Multidisciplinary ...
Jan 26, 2012 |
5 / 5 (1) |
0
Mutated Kras spins a molecular loop that launches pancreatic cancer
Scientists have connected two signature characteristics of pancreatic cancer, identifying a self-perpetuating "vicious cycle" of molecular activity and a new potential target for drugs to treat one of the most lehal forms ...
Jan 26, 2012 |
5 / 5 (1) |
0
Women with certain type of ovarian cancer and BRCA gene mutation have improved survival at 5 years
Among women with invasive epithelial ovarian cancer, patients having a germline (gene change in a reproductive cell that could be passed to offspring) mutation in the BRCA1 or BRCA2 genes was associated with improved 5-year ...
Jan 24, 2012 |
not rated yet |
0
Younger breast cancer patients have more adverse quality-of-life issues
Younger women with breast cancer experience a decrease in their health-related quality of life (QOL), associated with increased psychological distress, weight gain, a decline in their physical activity, infertility and early ...
Jan 20, 2012 |
5 / 5 (2) |
0
High risk oesophageal cancer gene discovered
New research from Queen Mary, University of London has uncovered a gene which plays a key role in the development of oesophageal cancer (cancer of the gullet).
Jan 19, 2012 |
not rated yet |
0
Drug improves survival of colorectal cancer patients, trial results show
An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were presented ...
Jan 18, 2012 |
not rated yet |
0
Lower risk of breast cancer occurrence but higher mortality amongst low-educated and immigrant women
(Medical Xpress) -- Low-educated and immigrant women run a lower risk of breast cancer occurrence than highly educated women and women born in Sweden. However, the risk of dying from breast cancer is higher for those low-educated ...
Jan 10, 2012 |
not rated yet |
0
Breakthrough in early cancer detection
Cape Cod-TV correspondent Melissa Chartrand went into the hospital three years ago to undergo a hysterectomy, a common procedure that was supposed to eliminate her abdominal pains. But for Melissa, a far more serious pain ...
Jan 10, 2012 |
not rated yet |
1
